Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IM CannabisIMCC -9.10%37 EV-to-FCF is 232.55 as of Jul. 24, 2026. GuruFocus rates IMCC with a GF Score™ of 37/100 and a GF Value™ of $1.26 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 568 Drug Manufacturers companies, IM Cannabis ranks worse than 93.66% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, IM Cannabis's Enterprise Value is $10.93 Mil.
IM Cannabis's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0.05 Mil. Therefore, IM Cannabis's EV-to-FCF for today is 232.55.
The historical rank and industry rank for IM Cannabis's EV-to-FCF or its related term are showing as below:
IMCC'
s EV-to-FCF Range Over the Past 10 Years
Min: -164.36 Med: -2.75 Max: 263.11
Current: 232.55
During the past 13 years, the highest EV-to-FCF of IM Cannabis was 263.11. The lowest was -164.36. And the median was -2.75.
IMCC's EV-to-FCF is ranked worse than 93.66% of 568
companies
in the Drug Manufacturers industry
Industry Median: 21.015
vs IMCC: 232.55
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IM Cannabis's PE Ratio (TTM) for today is calculated as:
IM Cannabis's share price for today is $0.116.
IM Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
IM Cannabis EV-to-FCF Related Terms
IM Cannabis EV-to-FCF Historical Data
* Premium members only.
The historical data trend for IM Cannabis's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IM Cannabis EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where IM Cannabis's EV-to-FCF falls into.
IM Cannabis's current Enterprise Value is $10.93 Mil.
IM Cannabis's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IM Cannabis (IMCC) has a EV-to-FCF of 232.55 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on IM Cannabis and its competitors. According to the industry distribution chart, IM Cannabis ranks #532 out of 568 companies in the Drug Manufacturers industry, placing it in the top 93.7%.
Is IM Cannabis' EV-to-FCF too high?
IM Cannabis' current EV-to-FCF is 232.55. The Drug Manufacturers industry median EV-to-FCF is 21.02. IM Cannabis' value of 232.55 is 1006.6% above this industry median. Based on the distribution chart, IM Cannabis ranks #532 out of 568 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, IM Cannabis has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' EV-to-FCF compare to BSPK and NPHC?
According to the Drug Manufacturers industry distribution chart, IM Cannabis ranks #532 out of 568 companies for EV-to-FCF. This places IM Cannabis in the lower half of its industry. The industry median EV-to-FCF is 21.02. IM Cannabis' value of 232.55 is 1006.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.02, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IM Cannabis's current EV-to-FCF of 232.55 is 1006.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on IM Cannabis and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IM Cannabis's current EV-to-FCF is 232.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.26, compared to a current price of $0.12 — trading 90.8% below its estimated fair value. The current EV-to-FCF is 232.55 and 1006.6% above the Drug Manufacturers industry median of 21.02. IM Cannabis' overall GF Score™ is 37/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For IM Cannabis (IMCC), the current EV-to-FCF is 232.55 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IM Cannabis (IMCC) Overvalued in 2026?
Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued.
The current stock price of $0.12 is trading 90.8% below its estimated GF Value™ of $1.26.
GuruFocus considers IM Cannabis to be Possible Value Trap.
Key valuation signals for IMCC:
EV-to-FCF: 232.55
GF Value™: $1.26 vs. price of $0.12 (90.8% below fair value)
Industry Position: 1006.6% above the Drug Manufacturers median (#532 of 568)
No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
37GF Score
Get the complete analysis for IMCC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMCC has been successfully added to your 
